Supplementary Tables – Low dose sublingual fentanyl improves quality of life in patients with breakthrough cancer pain at Palliative Care
收藏NIAID Data Ecosystem2026-03-13 收录
下载链接：
https://figshare.com/articles/dataset/Supplementary_Tables_Low_dose_sublingual_fentanyl_improves_quality_of_life_in_patients_with_breakthrough_cancer_pain_at_Palliative_Care/19145240
下载链接
链接失效反馈官方服务：
资源简介：
Supplementary Table
1. Low dose sublingual fentanyl improves quality of life in patients with
breakthrough cancer pain at Palliative Care
Patient
socio-demographic and clinical characteristics at baseline in the
subpopulations treated with medium-to-high fentanyl doses (≥200μg) for BTcP.
Supplementary Table
2. Low dose sublingual fentanyl improves quality of life in patients with
breakthrough cancer pain at Palliative Care
Clinical features
of background pain and BTcP at baseline in the subpopulations treated with
medium-to-high fentanyl doses (≥200μg) for BTcP
Supplementary Table
3. Low dose sublingual fentanyl improves quality of life in patients with
breakthrough cancer pain at Palliative Care
Evolution of
background pain and BTcP over the study period in the subpopulations treated
with medium-to-high fentanyl doses (≥200μg) for BTcP.
Supplementary Table
4. Low dose sublingual fentanyl improves quality of life in patients with
breakthrough cancer pain at Palliative Care
Quality of life
outcomes according to the EORTC QLQ-C30 in the subpopulations treated with
medium-to-high fentanyl doses (≥200μg) for BTcP.
Supplementary Table
5. Low dose sublingual fentanyl improves quality of life in patients with
breakthrough cancer pain at Palliative Care
Global impression
of improvement according to patient’s (PGI-I) and physician’s (CGI-I)
perspective in the subpopulations treated with medium-to-high fentanyl doses
(≥200μg) for BTcP.
创建时间：
2022-02-09
